Diabetes, cognitive function and dementia | Diabetes on the Net

For healthcare professionals only

Where

Online

When

July 7, 2020

Time

1:00 pm
&
7:00 pm
Share on facebook
Share on twitter
Share on linkedin
Share on email

Diabetes, cognitive function and dementia

Speaker: Richard Holt, Professor in Diabetes and Endocrinology, Southampton

Join us at either 1pm or 7pm, for an hour, and ask your questions.

This webinar has been developed, organised and funded by Novo Nordisk. For healthcare professionals only. Promotional information on insulin degludec (Tresiba®) will be discussed in this webinar. Click here to view prescribing information for insulin degludec (Tresiba®). Insulin degludec (Tresiba®) is indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.
  • Epidemiology of cognitive function and dementia in people with diabetes


  • Mechanisms linking diabetes and dementia


  • Consequences of co-morbidity


  • Clinical implications

    * Mandatory Field

    Register Free for

    Virtual PCDS

    SMART Update

    in diabetes

    We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.